| 1 |
Ali NA, O’Brien JM Jr, Dungan K，et al.Glucose variability and mortality in patients with sepsis[J]．Crit Care Med，2008，36(8): 2316-2321.
|
| 2 |
Bagshaw SM, Bellomo R, Jacka MJ，et al.The impact of early hypoglycemia and blood glucose variability on outcome in critical illness[J]．Critical Care，2009，13(3): R91.
|
| 3 |
Marik PE, Raghavan M．Stress-hyperglycemia，insulin and immunomodulation in sepsis[J]．Intensive Care Med，2004，30(5): 748-756.
|
| 4 |
Ceriello A, Ihnat MA.Glycemic variability.a new therapeutic challenge in diabetes and the critical care setting[J]．Diabet Med，2010，27(8): 862-867.
|
| 5 |
Cho SK, Huh JH, Yoo JS，et al.HOMA-estimated insulin resistance as an independent prognostic factor in patients with acute pancreatitis[J]．Sci Rep，2019，9(1): 14894.
|
| 6 |
Giacco F, Brownlee M．Oxidative stress and diabetic complications[J]．Circ Res, 2010，107(9): 1058-1070.
|
| 7 |
Xia J, Yin C．Glucose variability and coronary artery disease[J]．Heart Lung Circ，2019，28(4): 553-559.
|
| 8 |
Mendez CE, Der Mesropian PJ, Mathew RO，et al.Hyperglycemia and acute kidney injury during the perioperative period[J]．Curr Diab Rep，2016，16(1) : 10.
|
| 9 |
Quagliaro L, Piconi L, Assaloni R，et al.Intermittent high glucose enhances ICAM-1，VCAM-1 and e-selectin expression in human umbilical vein endothelial cells in culture：the distinct role of protein kinase C and mitochondrial superoxide production[J]．Atherosclerosis，2005，183(2): 259-267.
|
| 10 |
Sun J, Xu Y, Sun S，et al.Intermittent high glucose enhances cell proliferation and VEGF expression in retinal endothelial cells：the role of mitochondrial reactive oxygen species[J]．Mol Cell Biochem，2010，343(1-2): 27-35.
|
| 11 |
Satya Krishna SV, Kota SK, Modi KD.Glycemic variability：clinical implications[J]．Indian J Endocrinol Metab，2013，17(4): 611-619.
|
| 12 |
Eslami S, Taherzadeh Z, Schultz MJ，et al.Glucose variability measures and their effect on mortality：a systematic review[J]．Intensive Care Med，2011，37(4): 583-593.
|
| 13 |
Krinsley JS.Glycemic variability：a strong independent predictor of mortality in critically ill patients[J]．Crit Care Med，2008，36(11): 3008-3013.
|
| 14 |
Van den Berghe G, Wouters PJ, Bouillon R，et al.Outcome benefit of intensive insulin therapy in the critically ill：Insulin dose versus glycemic control[J]．Crit Care Med，2003，31(2): 359-366.
|
| 15 |
Balloni A, Lari F, Giostra F．Evaluation and treatment of hyperglycemia in critically ill patientss[J]．Acta Biomed，2016，87(3): 329-333.
|
| 16 |
Van Cromphaut SJ, Vanhorebeek I, Van den Berghe G．Glucose metabolism and insulin resistance in sepsi[J]．Curr Pharm Des，2008，14(19): 1887-1899.
|
| 17 |
Hernandez R, Teruel T, Lorenzo M．Akt mediates insulin induction of glucose uptake and up-regulation of GLUT4 gene expression in brown adipocytes[J]．FEBS Lett，2001，494(3): 225-231.
|
| 18 |
Krinsley JS.Glycemic variability and mortality in critically Ill patients：the impact of diabetes[J]．J Diabetes Sci Technol，2009，3(6): 1292-1301.
|
| 19 |
Lundelin K, Vigil L, Bua S，et al.Differenees in complexity of glycemic profile in survivors and nonsurvivors in an intensive care unit：a pilot study[J]．Crit Care Med，2010，38(3): 849-854.
|
| 20 |
Devanesan A, Lloyd J, Samad H，et al.Glycaemic control in intensive care everything in moderation[J]．J Intensive Care Soc，2016，17(4): 280-283.
|
| 21 |
Egi M, Bellomo R, Stachowski E，et al.Variability of blood glucose concentration and short-term mortality in critically ill patients[J]．Anesthesiology，2006，105(2): 244-252.
|
| 22 |
van Dan Berghe G, Wouters P, Weekers F，et al.Intensive insulin therapy in critically ill patients[J]．N Engl J Med，2001，345(19): 1359-1367.
|
| 23 |
侯静，许媛．感染性休克治疗中的血糖控制及评价[J]．中国实用外科杂志，2009，29(12): 986-988.
|
| 24 |
van Hooijdonk RT, Mesotten D, Krinsley JS，et al.Sweet spot glucose control in the intensive care unit[J]．Semin Respir Crit Care Med，2016，37(1): 57-67.
|
| 25 |
Griesdale DE, de Souza RJ, van Dam RM，et al.Intensive insulin therapy and mortality among critically ill patients：a meta-analysis including NICE-SUGAR study data [J]．CMAJ，2009，180(8): 821-827.
|
| 26 |
Hermanides J, Vriesendorp TM, Bosman RJ，et al.Glucose variability is associated with intensive care unit mortality[J]．Crit Care Med，2010，38(3): 838-842.
|
| 27 |
Oddo M, Schmidt JM, Carrera E，et al.Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury：a microdialysis study[J]．Crit Care Med，2008，36(12): 3233-3238.
|
| 28 |
Meyfroidt G．Blood glucose amplitude variability in critically ill patients[J]．Minerva Anestesiol，2015，81(9): 1010-1018.
|
| 29 |
NICE-SUGAR Study Investigators，Finfer S, Chittock DR，et al.Intensive versus conventional glucose control in critically ill patients [J]．N Engl J Med，2009，360(13): 1283-1297.
|
| 30 |
American Diabetes Association.Standards of medical care in diabetes-2009[J]. Diabetes Care，2009，32(Suppl 1): S13-S61.
|
| 31 |
Young Deborah Rohm, Hivert Marie-France, Alhassan Sofiya，et al.Sedentary behavior and cardiovascular morbidity and mortality：a science advisory from the american heart association[J]．Circulation，2016，134(13)，262-279.
|
| 32 |
Singh M, Upreti V, Singh Y，et al.Effect of glycemic variability on mortality in ICU settings a prospective observational study[J]．Indian J Endocrinol Metab，2018，22(5): 632-635.
|
| 33 |
Mojtahedzadeh M, Jafarieh A, Najafi A，et al.Comparison of metformin and insulin in the control of hyperglycaemia in non-diabetic critically ill patients[J]．Endokrynol Pol，2012，63(3): 206-211.
|
| 34 |
Ansari G, Mojtahedzadeh M, Kajbaf F，et al.How does blood glucose control with metformin influence intensive insulin protocols? evidence for involvement of oxidative stress and inflammatory cytokines[J]．Adv Ther, 2008，25(7): 681-702.
|
| 35 |
Karolina P, Chlup R, Jana Z，et al.Influence of oral antidiabetic drugs on hyperglycemic response to foods in persons with type 2 diabetes mellitus as assessed by continuous glucose monitoring system：a pilot study[J]．J Diabetes Sci Technol，2010，4(4): 983-992.
|
| 36 |
Ngaosuwan K, Ounchokdee K, Chalermchai T．Clinical outcomes of minimized hydrocortisone dosage of 100 mg/day on lower occurrence of hyperglycemia in septic shock patients[J]．Shock，2018，50(3): 280-285.
|
| 37 |
朱磊，李秀霞，刘漪珊，等．氢化可的松不同给药方式对脓毒性休克患者血糖影响的Meta分析[J]．中华危重病急救医学，2018，30(10): 915-919.
|
| 38 |
周淑琴，张守法，张伟，等．姜黄素对波动性高血糖处理下人脐静脉内皮细胞DNA氧化损伤的影响[J]．中国老年学杂志，2018，38(5): 1205-1207.
|
| 39 |
郝俊杰，孙贵新，李昕，等．医学救援中常见内科急危重症的识别与处理[J/CD]．中华卫生应急电子杂志，2018，4(2): 72-75.
|
| 40 |
中国研究型医院学会卫生应急学专业委员会，中国研究型医院学会心肺复苏学专业委员会，河南省医院协会心肺复苏专业委员会．创伤性休克急救复苏新技术临床应用中国专家共识(2019)[J/CD]．中华卫生应急电子杂志，2019，5(1): 1-6.
|